Perthera

15 articles about Perthera

• New Research Reveals Pancreatic Cancer Patients Who Receive Precision Medicine Live An Average Of One Year Longer Than Those Who Do Not

  3/3/2020

  Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to Get Tested Through a Molecular Profiling Platform

• Perthera Builds Its Senior Management Team

  4/7/2017

• Perthera's Chief Bioinformatics Officer Speaking At American Medical Informatics Association (AMIA) 2017 Joint Summits Panels

  3/28/2017

• Perthera Adds Germline Testing To Its Precision Cancer Analysis (PCA) For Cancer Patients

  3/24/2017

• Perthera Launches New Website To Provide "A New Understanding Of Precision Medicine And Cancer"

  3/9/2017

• Admiral James A. "Sandy" Winnefeld, Jr., (USN, RET) Becomes A Senior Advisor To Perthera

  2/28/2017

• George Davis Joins Perthera Board Of Directors

  2/16/2017

• Perthera Announces Partnership With Hope For Stomach Cancer Advocacy Organization

  2/14/2017

• Perthera Enters A Collaboration With Major Pharmaceutical Company To Identify Cancer Patients For Clinical Trials

  2/1/2017

• Perthera Announces Partnership With Lung Cancer Alliance To Provide No-Cost-To-Patient Precision Medicine Services Across The U.S.

  11/15/2016

• Perthera Secures $8.7 Million Investment From Pilot Growth Equity To Expand Global Leadership In Precision Cancer Analysis ("PCA")

  6/29/2016

• Thomas Jefferson University Taps Perthera For Multi-Omic Molecular Diagnostic Analyses

  9/24/2015

• Personalized Cancer Solutions Innovator Perthera Named Finalist In Virginia Velocity Business Plan Competition

  9/4/2015

• Perthera To Host Breakfast Roundtable During ASCO Annual Meeting In Chicago

  5/18/2015

• Perthera Announces Andrew Mignatti As CEO

  3/4/2015